Accellix

Developer of immunotherapy-based assay delivery platform

placeSan Jose, California, United States calendar_todayFounded 2007 groups71 employees language accellix.com

Social engagement

Social engagement: 9.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Axcel, Broadoak Capital Partners, BioMerieux.

Investor typeCountShare
Private equity125%
Bank & private debt125%
Other / undisclosed250%

Recent activity

4 Jun 2026
Event
CYTO2026
13 Mar 2026
Event
Advanced Therapies Congress 2026
2 Mar 2026
Event
Endpoints News' Cell and Gene Day 2026
Coming soon